Ross Acquisition II in a proxy filing seeks to extend its deal deadline to March 2024. The move follows the termination last week of a $320 million merger agreement with Hong Kong-based APRINOIA Therapeutics.
If the extension is approved, the new deadline will mark the three-year anniversary of the SPAC’s IPO.
Ross II’s cash in trust stands at about $65 million, down from the $350.6 million the SPAC held when the APRINOIA deal was announced in January.
The SPAC was founded by Wilbur Ross, former commerce secretary during the Trump Administration. Read more.
